Union Cabinet approves Inter-Institutional Agreement between India and US for 3D bioprinting & regenerative medicine
Published: July 18, 2019
The Union Cabinet has given ex-post facto approval to the Inter-Institutional Agreement (IIA) between India and the USA in the areas of regenerative medicine and 3D bioprinting, new technologies, exchange of scientific ideas/information and technologies, and joint use of scientific infrastructure. The purpose of the Agreement is to contribute towards the development of research and education of both the Institutions through academic collaboration. The joint research projects, training programmes, conferences, seminars etc. under this Agreement will be open to all qualified scientists and technologists, and will be supported on the basis of scientific merit and excellence. Scientific research and technology development in the areas of regenerative medicine and 3D bio-printing will have potential for generation of new Intellectual Property, processes, prototypes or products.